ARTICLE | Clinical News
Naloxone Hydrochloride Nasal Spray regulatory update
February 24, 2017 2:19 AM UTC
EMA accepted for review an MAA from Adapt for Naloxone Hydrochloride Nasal Spray to treat opioid overdose. Adapt markets the opioid antagonist nasal spray in the U.S. as Narcan Nasal Spray. Adapt has ...